欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2000, Vol. 5 ›› Issue (3): 210-212.

• 论著 • 上一篇    下一篇

不同来源的抗乙肝免疫核糖核酸对慢性乙型肝炎患者的免疫调节作用1

余永胜, 陈有华   

  1. 皖南医学院弋矶山医院传染科,芜湖241001
  • 收稿日期:2000-02-16 修回日期:2000-03-03 出版日期:2000-09-26 发布日期:2020-11-25
  • 作者简介:余永胜,男,34岁,主治医师,硕士,主要从事感染性疾病临床研究。
  • 基金资助:
    1本课题为安徽省重点科研项目(№99022016)

Immune modulation of anti-HBV iRNA from different sources in patients with chronic hepatitis B

YU Yong-Sheng, CHEN You-Hua   

  1. Yijishan Hospital,Wannan Medical College,Wuhu 241001
  • Received:2000-02-16 Revised:2000-03-03 Online:2000-09-26 Published:2020-11-25

摘要: 目的 探讨HBV 感染后乙肝保护抗体抗-HBs 产生机体外周淋巴细胞iRNA (h-iRNA)对慢性乙型肝炎的免疫调节作用,并与目前单用HBsAg 免疫动物来源的抗乙肝iRNA(a-iRNA)相比较。方法 利用四甲基偶氮唑盐(MTT)法观察h-iRNA对慢性乙肝患者外周淋巴细胞HBV抗原特异增殖反应的影响。结果 在HBsAg刺激组中,h-iRNA、a-iRNA 对慢性乙肝患者外周HBsAg特异淋巴细胞增殖反应皆有一定程度的增强作用;但HBcAg刺激组中,h-iRNA对慢性乙肝患者HBcAg特异淋巴细胞增殖反应具有增强作用,与a-iRNA相比,差异有显著性意义。结论 HBV感染后保护抗体产生机体外周淋巴细胞iRNA 具有增强慢性乙型肝炎患者淋巴细胞对HBV 抗原的特异增殖反应,对主要靶抗原HBcAg 特异淋巴细胞增殖反应的增强作用,有利于清除肝内HBV。目前单用HBsAg 免疫动物的抗乙肝iRNA,不具有对HBV 其它抗原的免疫信息,尤其是不能对免疫细胞识别肝细胞内HBV 的主要靶抗原HBcAg 产生有效免疫作用,可能是影响其疗效的重要原因。

关键词: 乙型肝炎, 乙肝保护抗体, 免疫核糖核酸, 淋巴细胞增殖反应

Abstract: Aim To explore the function of immune modulation of anti-HBV iRNA in patient s with chronic hepatitis B(CHB).Methods Peripheral blood lymphocyte iRNA was prepared from anti-HBs positive human body with HBV complete clearance after HBV infection(h-iRNA). The effect of h-iRNA on HBV specific lymphocyte proliferative response of peripheral lymphocyte from patient s with CHB was observed by using MT T method and was compared with that by HBV specific iRNA from animal immunized only by HBsAg (a-iRNA).Results Both h-iRNA and a-iRNA increased the level of peripheral lymphocyte proliferative response to HBsAg in patient s with CHB to some degree.In grouPof HBcAg,only h-iRNA showed its enhancement of HBcAg specific lymphocyte proliferative response.Conclusion sh-iRNA can increase HBV specific lymphocyte proliferative response in patients with CHB and the function of increasing HBcAg specific lymphocyte proliterative response contributes to HBV clearance.

Key words: hepatitis B, HBV protective antibody, iRNA, lymphocyte proliferative response

中图分类号: